Ruonan Yang

756 total citations · 1 hit paper
19 papers, 528 citations indexed

About

Ruonan Yang is a scholar working on Oncology, Cognitive Neuroscience and Molecular Biology. According to data from OpenAlex, Ruonan Yang has authored 19 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Cognitive Neuroscience and 2 papers in Molecular Biology. Recurrent topics in Ruonan Yang's work include Medication Adherence and Compliance (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers) and Functional Brain Connectivity Studies (2 papers). Ruonan Yang is often cited by papers focused on Medication Adherence and Compliance (2 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers) and Functional Brain Connectivity Studies (2 papers). Ruonan Yang collaborates with scholars based in China, United States and Egypt. Ruonan Yang's co-authors include Wanhai Wang, Qian Chang, Xianchun Meng, Nan Gao, Fangyuan Tian, Zhaoyan Chen, Jianhua Xu, Nan Gao, Kacey Fang and Lily Chang and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Science Translational Medicine and Annals of the Rheumatic Diseases.

In The Last Decade

Ruonan Yang

16 papers receiving 521 citations

Hit Papers

Prognostic value of Systemic immune-inflammation index in... 2018 2026 2020 2023 2018 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruonan Yang China 8 270 98 91 87 56 19 528
Sven H. Loosen Germany 14 151 0.6× 101 1.0× 164 1.8× 186 2.1× 36 0.6× 99 713
Margarita Cariolou United Kingdom 5 374 1.4× 121 1.2× 77 0.8× 76 0.9× 22 0.4× 5 624
Meghan A. Cupp United States 6 247 0.9× 100 1.0× 79 0.9× 61 0.7× 17 0.3× 17 480
Steven T. Bird United States 16 68 0.3× 97 1.0× 69 0.8× 50 0.6× 52 0.9× 31 736
Paula F. Ypma Netherlands 15 100 0.4× 34 0.3× 63 0.7× 63 0.7× 162 2.9× 57 770
Sanjeev Balu United States 15 144 0.5× 39 0.4× 175 1.9× 81 0.9× 123 2.2× 48 988
Jorge Arellano United States 18 354 1.3× 212 2.2× 277 3.0× 38 0.4× 29 0.5× 40 880
Xiaonan Shao China 14 56 0.2× 177 1.8× 52 0.6× 110 1.3× 53 0.9× 52 575
Mahsima Shabani United States 12 68 0.3× 52 0.5× 46 0.5× 57 0.7× 131 2.3× 39 445

Countries citing papers authored by Ruonan Yang

Since Specialization
Citations

This map shows the geographic impact of Ruonan Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruonan Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruonan Yang more than expected).

Fields of papers citing papers by Ruonan Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruonan Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruonan Yang. The network helps show where Ruonan Yang may publish in the future.

Co-authorship network of co-authors of Ruonan Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Ruonan Yang. A scholar is included among the top collaborators of Ruonan Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruonan Yang. Ruonan Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Wang, Huilan, Q. Wang, Yuanzheng Wu, et al.. (2025). MEK1/2 inhibitors suppress pathological α-synuclein and neurotoxicity in cell models and a humanized mouse model of Parkinson’s disease. Science Translational Medicine. 17(798). eadp4625–eadp4625. 2 indexed citations
3.
Ren, Yudan, et al.. (2025). SFPGCL: Specificity-preserving federated population graph contrastive learning for multi-site ASD identification using rs-fMRI data. Computerized Medical Imaging and Graphics. 124. 102558–102558.
4.
Yang, Ruonan, et al.. (2024). A Study on Highway Traffic Volume Forecasting Based on the SARIMA-GCN-LSTM Model. 1788–1794. 1 indexed citations
5.
Fei, Fei, et al.. (2024). A Wearable Visually Impaired Assistive System Based on Semantic Vision SLAM for Grasping Operation. Sensors. 24(11). 3593–3593. 3 indexed citations
7.
Yang, Lan, Ruonan Yang, Jing Cao, et al.. (2023). AB0535 EFFICACY AND SAFETY OF BELIMUMAB IN PATIENTS WITH CHILDHOOD-ONSET SYSTEMIC LUPUS ERYTHEMATOSUS:A SYSTEMATIC REVIEW AND META-ANALYSIS. Annals of the Rheumatic Diseases. 82. 1466–1466.
8.
Fei, Fei, et al.. (2023). Biometric Identification Based on PCA for Palmprint Feature Extraction. 475–479. 1 indexed citations
9.
Tian, Fangyuan, Ruonan Yang, Zhaoyan Chen, Xiaoxia Duan, & Ping Yuan. (2022). The prevalence and factors associated with potentially inappropriate medication use in Chinese older outpatients with cancer with multimorbidity. Journal of Geriatric Oncology. 13(5). 629–634. 7 indexed citations
10.
Tian, Fangyuan, Mengnan Zhao, Zhaoyan Chen, & Ruonan Yang. (2022). Prescription of Potentially Inappropriate Medication Use in Older Cancer Outpatients With Multimorbidity: Concordance Among the Chinese, AGS/Beers, and STOPP Criteria. Frontiers in Pharmacology. 13. 857811–857811. 12 indexed citations
11.
Tian, Fangyuan, Ruonan Yang, & Zhaoyan Chen. (2022). Safety and efficacy of COVID‐19 vaccines in children and adolescents: A systematic review of randomized controlled trials. Journal of Medical Virology. 94(10). 4644–4653. 48 indexed citations
12.
Yang, Ruonan, Hongyang Wang, Qinghai Wang, et al.. (2022). Antitumor activity of RUNX3: Upregulation of E-cadherin and downregulation of the epithelial–mesenchymal transition in clear-cell renal cell carcinoma. Open Life Sciences. 17(1). 1579–1590. 1 indexed citations
13.
Jin, Yan, et al.. (2021). KAT6A is associated with sorafenib resistance and contributes to progression of hepatocellular carcinoma by targeting YAP. Biochemical and Biophysical Research Communications. 585. 185–190. 16 indexed citations
14.
Yang, Ruonan, et al.. (2021). Sarcopenia as a predictor of postoperative risk of complications, mortality and length of stay following gastrointestinal oncological surgery. Annals of The Royal College of Surgeons of England. 103(9). 630–637. 39 indexed citations
15.
Yang, Ruonan, et al.. (2020). Using visual and/or kinesthetic information to stabilize intrinsic bimanual coordination patterns is a function of movement frequency. Psychological Research. 85(2). 865–878. 5 indexed citations
16.
Yang, Ruonan, Nan Gao, Qian Chang, Xianchun Meng, & Wanhai Wang. (2018). The role of IDO, IL‐10, and TGF‐β in the HCV‐associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Journal of Medical Virology. 91(2). 265–271. 33 indexed citations
17.
Yang, Ruonan, Qian Chang, Xianchun Meng, Nan Gao, & Wanhai Wang. (2018). Prognostic value of Systemic immune-inflammation index in cancer: A meta-analysis. Journal of Cancer. 9(18). 3295–3302. 300 indexed citations breakdown →
18.
Gao, Nan, Ruonan Yang, Zhen Meng, & Wanhai Wang. (2018). The prognostic value of C-reactive protein/albumin ratio in nasopharyngeal carcinoma: a meta-analysis. Bioscience Reports. 38(6). 21 indexed citations
19.
Brown, Tamara, Gerlinde Pilkington, Angela Boland, et al.. (2013). Clinical effectiveness of first-line chemoradiation for adult patients with locally advanced non-small cell lung cancer: a systematic review. Health Technology Assessment. 17(6). 1–99. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026